CRC screening at age 45 What does the modeling suggest?
|
|
- William Carroll
- 5 years ago
- Views:
Transcription
1 CRC screening at age 45 What does the modeling suggest? Elisabeth Peterse Erasmus University Medical Center, Rotterdam, The Netherlands
2 Possible conflicts of interest No disclosures. Elisabeth Peterse
3 Background In 2016, the CISNET models performed analyses for the United States Preventive Services Task Force Two out of three CISNET models recommended screening from age 45 to 75 years with a 15 year colonoscopy interval. MISCAN-Colon (microsimulation model from Erasmus) recommended screening from age 50 to 75 years with a 10 year colonoscopy interval. 2018: Update screening guideline American Cancer Society Re-evaluation of the optimal screening strategies using MISCAN-Colon Elisabeth Peterse
4 Increase in young-onset CRC While overall incidence is declining, incidence <50 is increasing Rectal Cancers Elisabeth Peterse Siegel et al. JNCI 2017
5 Aim The CISNET models are calibrated to data This period is selected because there was no screening in this period They do not take the recent increase in young-onset CRC into account Research question: Are the optimal age to start screening, age to end screening and screening interval affected by the increase in CRC incidence rate observed in young adults? Elisabeth Peterse
6 Methods Elisabeth Peterse
7 Incorperation higher incidence in MISCAN-Colon Cohort Rate Ratio Set as a reference as this cohort is 40 in 1975 (model is calibrated on ) Used as model input for increased incidence as these are the 40-year-olds in 2015 As it is a cohort effect, we assumed that the current 40 year olds will carry forward an increased CRC risk when they age Provided by Rebecca L. Siegel, American Cancer Society
8 Strategies analyzed We simulated a population of 40-year-olds without previous CRC screening We assumed perfect adherence to screening, diagnostic follow-up and surveillance Screening Modality Age to Start Screening (years) Age to End Screening (years) Screening Interval (years) No. Of (Unique) Strategies No screening 1 (1) Colonoscopy 40,45,50 75,80,85 5,10,15 27 (20) Stool-based tests - Fecal immunochemical test 40,45,50 75,80,85 1,2,3 27 (27) - High-sensitivity guaiac-based fecal occult blood test 40,45,50 75,80,85 1,2,3 27 (27) - Multitarget stool DNA test 40,45,50 75,80,85 1,3,5 27 (27) Flexible sigmoidoscopy 40,45,50 75,80,85 5,10 18 (15) Computed tomographic colonography 40,45,50 75,80,85 5,10 18 (15) Total 145 (132) Elisabeth Peterse
9 Main outcomes Life-years gained (benefit) Number of colonoscopies (burden) Efficiency Ratio= Incremental colonoscopies w.r.t. previous efficient strategy Incremental life-years gained w.r.t. previous efficient strategy Applied efficiency ratio thresholds of 40 Based on the accepted 39 in USPSTF analysis Elisabeth Peterse
10 Results Elisabeth Peterse
11 Efficient Frontier Colonoscopy Screening strategies Elleke Peterse
12 Step 1: In or near the efficient frontier Elleke Peterse
13 Step 2: Effective as current recommendation
14 Step 3: Efficiency ratio < 40 ΔLYG ΔCOL Efficiency Ratio = ΔCOL ΔLYG = 32
15 Step 3: Efficiency ratio < 40 ER=32 ER=48
16 Step 3: Efficiency ratio < 40 ER=32 ER=48
17 Step 4: Select the most effective strategy ER=32 ER=48 Elleke Peterse
18 Model recommendations Modality Age to start screening (years) Age to stop screening (years) Screening interval (years) Stool tests Results per year-olds SIGs CTCs COLs Life-years gained CRC Deaths Averted Colonoscopy Stool test: FIT Flexible Sigmoidoscopy CT colonography Elisabeth Peterse
19 Conclusion Because of the increase in young-onset colorectal cancer, screening initiation at age 45 has a favorable balance between screening benefits and burden. Elisabeth Peterse
20 Acknowledgements Department of Public Health, Erasmus MC, Rotterdam, The Netherlands Reinier G.S. Meester Iris Lansdorp-Vogelaar Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA Ann G. Zauber Jennifer C. Chen American Cancer Society, Atlanta, GA, USA Rebecca L. Siegel Robert A. Smith University of Colorado Cancer Center, Aurora, CO, USA Andrea Dwyer Dennis J. Ahnen Elisabeth Peterse
21 Elisabeth Peterse
22 Population Simulation Model Input MISCAN program Output Results Demography assumptions Natural history assumptions (incl. risk level) Screening assumptions Demography part Natural history part Screening part Cancer incidence and mortality without screening Cancer incidence and mortality with screening Effects of screening Elleke Peterse
23 Important assumptions We modelled the 1975 birth cohort, so we increased incidence by Incidence rate ratios from 1.2, 1.3, 2.3 and 2.4 explored in a sensitivity analyses As it is a cohort effect, we assumed that the current 40 year olds will carry forward an increased CRC risk when they age In a sensitivity analyses, we only increased incidence below age 50 We assumed that the increase in CRC incidence was caused by an increase in adenoma onset We explored faster adenoma progression in a sensitivity analyses Elleke Peterse
24 A cohort effect Increase is higher in whites than in blacks Increase is mainly present in rectal tumors and, to a lesser extend, in distal colon tumors Siegel et al. JNCI 2017, Siegel et al. CA 2017
25 Modality, and Age to Start, Age to End, Interval (years) Stool tests SIGs CTCs COLs LYG CRC Deaths Averted ER = ΔCOL/ ΔLYG ER < Benchmark LYG >= 90% of Benchmark Colonoscopy COL Yes Stool tests FIT Yes No FIT Yes No HSgFOBT Dom. - No FIT-DNA Dom. - No HSgFOBT Dom. - No FIT-DNA Dom - No FIT Yes Yes Yes HSgFOBT Dom. - Yes FIT-DNA No Yes Flexible sigmoidoscopy SIG Yes No SIG Yes Yes Yes CT colonography CTC Yes No CTC Yes Yes Yes Model Recom.
26 Efficient and near-efficient colonoscopy strategies Modality, and Age to Start, Age to End, Interval (years) Stool tests SIGs CTCs COLs LYG CRC Deaths Averted ER = ΔCOL/ ΔLYG COL COL * COL COL * COL COL * COL COL COL COL * COL * COL COL COL Nearefficient
27 Sensitivity analyses
28 Annual Percent Change (APC) in CRC mortality rates among adults aged 20 to 54 years Siegel et al. JAMA 2017
29 Efficient Frontier Stool-based strategies
30 Algorithm to find recommendable strategies
Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies Modeling Study for the US Preventive Services Task Force
Clinical Review & Education US Preventive Services Task Force MODELING STUDY Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies Modeling Study for the US Preventive Services
More informationACS Colorectal Cancer Screening Guideline for Average Risk Adults 2018
ACS Colorectal Cancer Screening Guideline for Average Risk Adults 2018 1 How are Cancer Screening Guidelines Developed? ACS Guideline Development Process Systematic Evidence Review & Modeling Reports [existing
More informationCost-effectiveness analysis of a screening programme. Iris Lansdorp-Vogelaar, PhD Department of Public Health Erasmus MC, Rotterdam
Cost-effectiveness analysis of a screening programme Iris Lansdorp-Vogelaar, PhD Department of Public Health Erasmus MC, Rotterdam Criteria of Wilson and Jungner (Bull World Health Organ. 1968) Why cost-effectiveness
More informationColorectal Cancer Screening
Colorectal Cancer Screening December 5, 2017 Connecticut Cancer Partnership 14th Annual Meeting Xavier Llor, M.D., PhD. Associate Professor of Medicine Co-Director, Cancer Genetics and Prevention Program
More informationScreening Start Age in Light of New ACS Guidelines. Charles Kahi, MD, MS Indiana University Richard L. Roudebush VAMC Indianapolis, Indiana, USA
Screening Start Age in Light of New ACS Guidelines, MD, MS Indiana University Richard L. Roudebush VAMC Indianapolis, Indiana, USA CRC Screening for Average-Risk Adults: 2018 Guideline Update from the
More informationColorectal Cancer Screening for Average-Risk Adults: 2018 Guideline Update From the American Cancer Society
CA CANCER J CLIN 2018;00:00 00 Colorectal Cancer Screening for Average-Risk Adults: 2018 Guideline Update From the American Cancer Society Andrew M. D. Wolf, MD 1 ; Elizabeth T. H. Fontham, MPH, DrPH 2
More informationIn its October 5, 2015, draft recommendation (draft
USPSTF Colorectal Cancer Screening Guidelines: An Extended Look at Multi-Year Interval Testing Barry M. Berger, MD, FCAP; Marcus A. Parton, SB; and Bernard Levin, MD, FACP Managed Care & Healthcare Communications,
More informationThe New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean?
The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean? Robert A. Smith, PhD Cancer Control, Department of Prevention and Early Detection American Cancer Society
More informationColorectal Cancer Screening Guideline Issue Brief Updated May 30 th, 2018
Colorectal Cancer Screening Guideline Issue Brief Updated May 30 th, 2018 Issue Summary The American Cancer Society has updated its colorectal screening guideline, which have been published in CA: A Journal
More informationCost-effectiveness of adenoma surveillance - the Dutch guidelines -
Cost-effectiveness of adenoma surveillance - the Dutch guidelines - WEO working group adenoma surveillance 20 May, 2016 Iris Lansdorp-Vogelaar, PhD On behalf of the SAP study-group Introduction Adenoma
More informationColorectal Cancer Screening in Later Life: Blum Center Rounds
Colorectal Cancer Screening in Later Life: Blum Center Rounds OCTOBER 10, 2018 Agenda CRC Screening and Surveillance Recommendation Screening for Colon Cancer later in life Discussion and listening Families
More informationCancer Screening 2009: New Tests, New Choices
Objectives Cancer Screening 2009: New Tests, New Choices UCSF Annual Review in Family Medicine April 21, 2009 Michael B. Potter, MD Professor, Clinical Family and Community Medicine UCSF School of Medicine
More informationCOLORECTAL CANCER. Colorectal Cancer (CRC) 3 rd most common cancer in U.S. 3 rd deadliest cancer in U.S. 12/4/2014
The heart and science of medicine. UVMHealth.org/CancerCenter COLORECTAL CANCER Claire Verschraegen, MD Co-Director University of Vermont Cancer Center 1 Colorectal Cancer (CRC) 3 rd most common cancer
More informationCLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING
CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING This guideline is designed to assist practitioners by providing the framework for colorectal cancer (CRC) screening, and is not intended to replace
More informationIARC Handbook Volume 17: Colorectal Cancer Screening. Béatrice Lauby-Secretan, PhD on behalf of the IARC Working Group for Volume 17
IARC Handbook Volume 17: Colorectal Cancer Screening Béatrice Lauby-Secretan, PhD on behalf of the IARC Working Group for Volume 17 IARC Handbooks of Cancer Prevention An important part of cancer prevention
More informationThank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements
Thank You to Our Sponsors: University at Albany School of Public Health NYS Department of Health Evaluations & CE Credits Nursing Contact Hours, CME and CHES credits are available. Please visit www.phlive.org
More informationCOLON CANCER SCREENING: AN UPDATE
Overview COLON CANCER SCREENING: AN UPDATE Siddharth Verma, DO, JD Rutgers New Jersey Medical School Background Screening Updates in Specific Populations African Americans CRC in the younger age USPSTF
More informationGrand Rounds. Des Moines University. May 5, Durado Brooks, MD, MPH Director, Cancer Control Intervention American Cancer Society
Grand Rounds Des Moines University May 5, 2016 Durado Brooks, MD, MPH Director, Cancer Control Intervention American Cancer Society Case Summary Mrs. J is a 56 y o w female complaining of always tired;
More informationGet tested for. Colorectal cancer. Doctors know how to prevent colon or rectal cancer- and you can, too. Take a look inside.
Get tested for Colorectal cancer Doctors know how to prevent colon or rectal cancer- and you can, too. Take a look inside. 1 If you re 50 or older, you need to get tested for colorectal cancer. It s one
More informationCologuard Screening for Colorectal Cancer
Pending Policies - Medicine Cologuard Screening for Colorectal Cancer Print Number: MED208.056 Effective Date: 08-15-2016 Coverage: I.Cologuard stool DNA testing may be considered medically necessary for
More informationThe choice of methods for Colorectal Cancer Screening; The Dutch experience
The choice of methods for Colorectal Cancer Screening; The Dutch experience Monique van Leerdam, Gastroenterologist, NKI-AVL, Amsterdam The Netherlands Colorectal cancer CRC 2 nd cause of cancer related
More informationImproving Outcomes in Colorectal Cancer: The Science of Screening. Colorectal Cancer (CRC)
Improving Outcomes in Colorectal Cancer: The Science of Screening Tennessee Primary Care Association October 23, 2014 Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancers Colorectal Cancer
More informationColon Cancer Screening Past, Present & Future
Colon Cancer Screening Past, Present & Future Steve Lanspa, MD August 25, 2018 Dr. Lanspa has listed no financial interest/arrangement that would be considered a conflict of interest. Learning Objectives
More informationThe Dutch bowel cancer screening program Relevant lessions for Ontario
The Dutch bowel cancer screening program Relevant lessions for Ontario Ernst J Kuipers Erasmus MC University Medical Center Rotterdam - The Netherlands 1 Ismar Boas (1858 1938) Colorectal cancer screening
More informationNational Colonoscopy Study (NCS) Screening Colonoscopy versus Annual Fecal Occult Blood Test NCT
National Colonoscopy Study (NCS) Screening Colonoscopy versus Annual Fecal Occult Blood Test NCT 00102011 Ann Zauber Sidney Winawer, Michael O Brien, John Allen, Andrew Feld, Glenn Mills, Robin Mendelsohn,
More informationHOW TO EVALUATE ACTIVITIES INTENDED TO INCREASE AWARENESS AND USE OF COLORECTAL CANCER SCREENING. Using your toolkit to conduct an evaluation
EVALUATION TOOLKIT HOW TO EVALUATE ACTIVITIES INTENDED TO INCREASE AWARENESS AND USE OF COLORECTAL CANCER SCREENING Using your toolkit to conduct an evaluation Welcome Mary Doroshenk, MA Director National
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Zauber AG, Winawer SJ, O Brien MJ, et al. Colonoscopic polypectomy
More informationFecal Occult Blood Testing When Colonoscopy Capacity is Limited
DOI: 10.1093/jnci/djr385 Advance Access publication on November 9, 2011. The Author 2011. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
More informationBackground and Rationale for Gipson bill AB The imperative for colonoscopy after a positive FOBT (Fecal Occult Blood Test)
Background and Rationale for Gipson bill AB 1763 The imperative for colonoscopy after a positive FOBT (Fecal Occult Blood Test) The Affordable Care Act (ACA) requires all private insurers (except grandfathered
More informationUpdates in Colorectal Cancer Screening & Prevention
Updates in Colorectal Cancer Screening & Prevention Swati G. Patel, MD MS Assistant Professor of Medicine Division of Gastroenterology & Hepatology Gastrointestinal Cancer Risk and Prevention Clinic University
More informationColorectal Cancer Screening. Dr Kishor Muniyappa 2626 Care Drive, Suite 101 Tallahassee, FL Ph:
Colorectal Cancer Screening Dr Kishor Muniyappa 2626 Care Drive, Suite 101 Tallahassee, FL 32308 Ph: 850-297-0351 What we ll be talking about How common is colorectal cancer? What is colorectal cancer?
More informationTechnical Considerations: the past, present and future of simulation modeling of colorectal cancer
Technical Considerations: the past, present and future of simulation modeling of colorectal cancer Siddhartha Nambiar, Rachel Townsley, Maria Mayorga North Carolina State University Kristen Hassmiller
More informationThe U.S. Preventive Services Task Force (USPSTF) makes
Annals of Internal Medicine Clinical Guidelines Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement U.S. Preventive Services Task Force* Description: Update of
More informationJoint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies. Ashish Sangal, M.D.
Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies Ashish Sangal, M.D. Cancer Screening: Consensus & Controversies Ashish Sangal, MD Director,
More informationColorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005
Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005 David Lieberman MD Chief, Division of Gastroenterology Oregon Health and Science University Portland VAMC Portland, Oregon
More informationColorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society
Colorectal Cancer: Preventable, Beatable, Treatable American Cancer Society Reviewed/Revised May 2018 What we ll be talking about How common is colorectal cancer? What is colorectal cancer? What causes
More informationQuality ID #113 (NQF 0034): Colorectal Cancer Screening National Quality Strategy Domain: Effective Clinical Care
Quality ID #113 (NQF 0034): Colorectal Cancer Screening National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE: Process DESCRIPTION: Percentage
More informationColorectal Cancer Disparities: Addressing the Challenge
Colorectal Cancer Disparities: Addressing the Challenge Inaugural Cancer Disparities Conference The Ohio State University Wexner Medical Center March 28, 2015 Durado Brooks, MD, MPH Cancer Disparities:
More informationStaging and survival of colorectal cancer (CRC) in octogenarians: Nationwide Study of US Veterans
Original Article Staging and survival of colorectal cancer (CRC) in octogenarians: Nationwide Study of US Veterans Gurjiwan Sing Virk 1, Mikram Jafri 2, Syed Mehdi 3, Christopher Ashley 4 1 Department
More informationColon Cancer Screening. A Provider Opinion Survey
Colon Cancer Screening A Provider Opinion Survey 1. Background Information What is colon cancer? Who needs to be screened? Colorectal Cancer» Presence of abnormal cells in the colon or rectum that divide
More informationStool DNA Testing to Screen for Colorectal Cancer in the Medicare Population A Cost-Effectiveness Analysis
Article Annals of Internal Medicine Stool DNA Testing to Screen for Colorectal Cancer in the Medicare Population A Cost-Effectiveness Analysis Iris Lansdorp-Vogelaar, PhD; Karen M. Kuntz, ScD; Amy B. Knudsen,
More informationObjectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background
Colorectal Cancer Screening Payam Afshar, MS, MD Kaiser Permanente, San Diego Objectives Colorectal cancer background Colorectal cancer screening populations Colorectal cancer screening modalities Colonoscopy
More informationColorectal Cancer Screening. Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital
Colorectal Cancer Screening Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital March, 2018 CRC Epidemiology 4th most common malignancy in US (136,000 cases/yr) 2nd
More informationCOLORECTAL CANCER SCREENING &THE FECAL IMMUNOCHEMICAL TEST (FIT) MATHEW ESTEY, PHD, FCACB CLINICAL CHEMIST
COLORECTAL CANCER SCREENING &THE FECAL IMMUNOCHEMICAL TEST (FIT) MATHEW ESTEY, PHD, FCACB CLINICAL CHEMIST MATHEW.ESTEY@DYNALIFEDX.COM FACULTY /PRESENTER DISCLOSURE FACULTY: MATHEW ESTEY RELATIONSHIPS
More informationSupplementary Online Content
Supplementary Online Content Meester R.G.S, Doubeni CA, Lansdorp-Vogelaar, et al. Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: a microsimulation
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Analysis of Human DNA in Stool Samples as a Page 1 of 11 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Analysis of Human DNA in Stool Samples as a Technique for
More informationEarly detection and screening for colorectal neoplasia
Early detection and screening for colorectal neoplasia Robert S. Bresalier Department of Gastroenterology, Hepatology and Nutrition. The University of Texas. MD Anderson Cancer Center. Houston, Texas U.S.A.
More informationCitation for published version (APA): Wijkerslooth de Weerdesteyn, T. R. (2013). Population screening for colorectal cancer by colonoscopy
UvA-DARE (Digital Academic Repository) Population screening for colorectal cancer by colonoscopy de Wijkerslooth, T.R. Link to publication Citation for published version (APA): Wijkerslooth de Weerdesteyn,
More informationLearning and Earning with Gateway Professional Education CME/CEU Webinar Series
Learning and Earning with Gateway Professional Education CME/CEU Webinar Series Best Practices for Colorectal Cancer Screening March 14, 2018 12:00pm 1:00pm Robert A. Smith, PhD Vice President, Cancer
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Analysis of Human DNA in Stool Samples as a Page 1 of 12 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Analysis of Human DNA in Stool Samples as a Technique for
More informationColorectal Cancer Screening
Colorectal Cancer Screening Colonoscopy is the gold standard for colorectal cancer screening 2 Focus on Colorectal Cancer Screening at Piedmont Healthcare Screening for colorectal cancer saves lives. Of
More informationColorectal Cancer Screening and Risk Assessment Workflow. Documentation Guide for Health Center NextGen Users
Colorectal Cancer Screening and Risk Assessment Workflow Documentation Guide for Health Center NextGen Users Colorectal Cancer Screening and Risk Assessment Workflow and Documentation Guide for Health
More informationStudy population The study population comprised a hypothetical cohort of 50-year-olds at average risk of CRC.
Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy Hassan C, Zullo A, Laghi A, Reitano I, Taggi F, Cerro P, Iafrate F, Giustini M, Winn S, Morini S Record
More informationCRC Risk Factors. U.S. Adherence Rates Cancer Screening. Genetic Model of Colorectal Cancer. Epidemiology and Clinical Consequences of CRC
10:45 11:45 am Guide to Colorectal Cancer Screening SPEAKER Howard Manten M.D. Presenter Disclosure Information The following relationships exist related to this presentation: Howard Manten MD: No financial
More informationColorectal Cancer Screening in Washington State
Colorectal Cancer Screening in Washington State Susie Dade, Deputy Director, Washington Health Alliance March 25, 2016 Colorectal Cancer Roundtable Outline About the Alliance How we re doing in Washington
More informationIEHP UM Subcommittee Approved Authorization Guidelines Colorectal Cancer Screening with Cologuard TM for Medicare Beneficiaries
for Medicare Beneficiaries Policy: Based on our review of the available evidence, the IEHP UM Subcommittee adopts the use of Cologuard TM - a multi-target stool DNA test as a colorectal cancer screening
More informationGuidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer
Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer David A. Lieberman, 1 Douglas K. Rex, 2 Sidney J. Winawer,
More informationColorectal Cancer Screening and Surveillance
1 Colorectal Cancer Screening and Surveillance Jeffrey Lee MD, MAS Assistant Clinical Professor of Medicine University of California, San Francisco jeff.lee@ucsf.edu Objectives Review the various colorectal
More informationIncreasing Colorectal Cancer Screening Rates Why it s not as easy as you ve been told
INCREASING COLORECTAL CANCER SCREENING IN NYS Increasing Colorectal Cancer Screening Rates Why it s not as easy as you ve been told 5/15/17 Syracuse, NY Martin C. Mahoney, MD, PhD Roswell Park Cancer Institute
More information11/9/2015 OUTLINE. Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist
Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist Anil K Sharma MD FACP Professor of Clinical Medicine, University of Rochester Chief of Gastroenterology,
More informationFinancial Disclosers
Slide 1 Colorectal Cancer Screening Jason Hemming, MD NESGNA November 15, 2014 Slide 2 Bio Slide 3 Financial Disclosers I have no actual or potential conflict of interest relation to this presentation
More informationColon Cancer Screening. Layth Al-Jashaami, MD GI Fellow, PGY 4
Colon Cancer Screening Layth Al-Jashaami, MD GI Fellow, PGY 4 -Colorectal cancer (CRC) is a common and lethal cancer. -It has the highest incidence among GI cancers in the US, estimated to be newly diagnosed
More informationQuality ID #113 (NQF 0034): Colorectal Cancer Screening National Quality Strategy Domain: Effective Clinical Care
Quality ID #113 (NQF 0034): Colorectal Cancer Screening National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:
More informationColorectal cancer screening
26 Colorectal cancer screening BETHAN GRAF AND JOHN MARTIN Colorectal cancer is theoretically a preventable disease and is ideally suited to a population screening programme, as there is a long premalignant
More informationColorectal Cancer Screening in Ohio CHCs. Ohio Association of Community Health Centers
Colorectal Cancer Screening in Ohio CHCs Ohio Association of Community Health Centers 2 1/29/2015 Your Speakers Dr. Ted Wymyslo Ashley Ballard Randy Runyon 3 1/29/2015 Facts 3 rd most common cancer in
More informationDebate: General surveillance/screening for colon cancer in a resource constrained environment is imperative
Debate: General surveillance/screening for colon cancer in a resource constrained environment is imperative Dr. Meryl Oyomno Department of surgery, University of Pretoria INTRODUCTION Screening is the
More informationIncreasing Colorectal Cancer Screening in Wyoming. Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program
Increasing Colorectal Cancer Screening in Wyoming Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program Overview What is colorectal cancer? What are risk factors for
More informationHow to start a screening Program? WEO Colorectal Cancer Screening Committee Meeting Brasilia Nov R. Sáenz, FACG,FASGE
How to start a screening Program? WEO Colorectal Cancer Screening Committee Meeting Brasilia Nov 11 2017 R. Sáenz, FACG,FASGE Wheel has been discovered already Policy Planning Thanks to GBD Big Data CRC
More informationCT Colonography. A Radiologist s View of the Colon from Outside-In. Donny Baek, MD
CT Colonography A Radiologist s View of the Colon from Outside-In Donny Baek, MD Computed Tomography (CT) CT Image Reconstruction CT Image Reconstruction CT Image Reconstruction Colorectal Cancer Annual
More informationColon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011
Colon Cancer Screening and Surveillance Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011 Colorectal Cancer Preventable cancer Number 2 cancer killer in the USA Often curable if detected
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Virtual Colonoscopy / CT Colonography Page 1 of 19 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Virtual Colonoscopy / CT Colonography Professional Institutional
More informationColorectal Cancer Screening: Colonoscopy, Potential and Pitfalls. Disclosures: None. CRC: still a major public health problem
Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls Disclosures: None Jonathan P. Terdiman, M.D. Professor of Clinical Medicine University of California, San Francisco CRC: still a major public
More informationScreening for Colorectal Cancer: A Systematic Review for the U.S. Preventive Services Task Force
Evidence Synthesis Number 135 Screening for Colorectal Cancer: A Systematic Review for the U.S. Preventive Services Task Force Prepared for: Agency for Healthcare Research and Quality U.S. Department of
More informationOHSU Health System Office of Clinical Integration and Evidence-Based Practice Colorectal Cancer Screening Evidence Summary
OHSU Health System Office of Clinical Integration and Evidence-Based Practice Colorectal Cancer Screening Evidence Summary Date started: April 2017 Date completed: October 2017 Content Expert Team Members:
More informationACTIVITY DISCLAIMER DISCLOSURE. Alvin B. Lin, MD, FAAFP. Audience Engagement System Step 1 Step 2 Step 3. Learning Objectives.
ACTIVITY DISCLAIMER Colorectal Cancer Alvin B. Lin, MD, FAAFP The material presented here is being made available by the American Academy of Family Physicians for educational purposes only. Please note
More informationReferences Cleveland Clinic. Diseases and Conditions. Colorectal Cancer Overview. 29 October 2013
Colo-Alert Only available DNA based rapid test for early colorectal cancer detection. The earlier colon cancer is found, the easier it is to treat. This is why regular screening is worthwhile it has the
More information2017 CANCER ANNUAL REPORT
2017 CANCER ANNUAL REPORT A WORD FROM OUR LEADERSHIP We are pleased to present our 2017 Annual Report highlighting advances in state of the art cancer care at the Roper St. Francis Cancer Program. Our
More informationGuidelines for the Early Detection of Cancer
Guidelines for the Early Detection of Cancer The American Cancer Society recommends these cancer screening guidelines for most adults. Screening tests are used to find cancer before a person has any symptoms.
More informationScreening for Colorectal Cancer in the Elderly. The Broad Perspective
Screening for Colorectal Cancer in the Elderly Charles J. Kahi, MD, MSCR Indiana University School of Medicine Richard L. Roudebush VA Medical Center Indianapolis, Indiana ACG Regional Midwest Course Symposium
More informationPage 1. Cancer Screening for Women I have no conflicts of interest. Overview. Breast, Colon, and Lung Cancer. Jeffrey A.
Cancer Screening for Women 2017 Breast, Colon, and Lung Cancer Jeffrey A. Tice, MD Professor of Medicine Division of General Internal Medicine University of California, San Francisco I have no conflicts
More informationCancer Screening. Charuwan Akewanlop, MD Division of Medical Oncology Department of Medicine Faculty of Medicine Siriraj Hospital
Cancer Screening Charuwan Akewanlop, MD Division of Medical Oncology Department of Medicine Faculty of Medicine Siriraj Hospital Outline Definition and principles of cancer screening Cancer incidence and
More informationThe MISCAN-COLON simulation model for the evaluation of colorectal cancer screening
2 The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening 30 Chapter 2 Abstract A general model for evaluation of colorectal cancer screening has been implemented in the microsimulation
More informationPharmacogenomic and Metabolite Markers for Patients Treated with Thiopurines
Pharmacogenomic and Metabolite Markers for Patients Treated with Thiopurines Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana,
More informationCancer Screening & Prevention. Dr. Jamey Burton, MD, FAAFP
Cancer Screening & Prevention Dr. Jamey Burton, MD, FAAFP Cervical Cancer Breast Cancer Colon Cancer Prostate Cancer Lung Cancer How common is cervical cancer? What causes it? What screening is needed?
More informationColorectal Cancer Screening. Paul Berg MD
Colorectal Cancer Screening Paul Berg MD What is clinical integration? AMA Definition The means to facilitate the coordination of patient care across conditions, providers, settings, and time in order
More informationCancer Facts for Men FOR REVIEW ONLY
Cancer Facts for Men Prostate cancer The chance of getting prostate cancer goes up as a man gets older. Most prostate cancers are found in men over the age of 65. For reasons that are still unknown, African
More informationAppendix 1 This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.
Appendix 1 This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Cenin DR, St John DJB, Ledger MJN, et al. Optimising the
More informationScreening & Surveillance Guidelines
Chapter 2 Screening & Surveillance Guidelines I. Eligibility Coloradans ages 50 and older (average risk) or under 50 at elevated risk for colon cancer (personal or family history) that meet the following
More informationONCOLOGY OUTCOMES REPORT
2017 EVANGELICAL COMMUNITY HOSPITAL ONCOLOGY OUTCOMES REPORT One Hospital Drive, Lewisburg, PA 17837 570-522-2000 evanhospital.com Cancer Screening The Commission on Cancer requires annual dissemination
More informationSetting The setting was primary and secondary care. The economic study was carried out in Taiwan.
Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries Wu G H, Wang Y W, Yen A M, Wong J M, Lai H C, Warwick J, Chen T H Record Status This
More informationThey know how to prevent colon cancer
They know how to prevent colon cancer and you can, too. Take a look inside. If you re 50 or older, you need to get tested for colon cancer. It s one cancer that can actually be prevented! Colon cancer:
More informationHow to Increase Preventive Screening Rates in Practice: An Action Plan for Implementing A Primary Care Clinician s Evidence-Based Toolbox and Guide
How to Increase Preventive Screening Rates in Practice: An Action Plan for Implementing A Primary Care Clinician s Evidence-Based Toolbox and Guide CRC Toolkit and Guide Available at http://www.cancer.org/aspx/pcmanual/pcm.swf
More informationColorectal Cancer Screening: The Science Behind the Guidelines. CRC Incidence North Dakota. Colorectal Cancer (CRC) CRC Incidence North Dakota
Reaching 80% Screened For Colorectal Cancer by 2018: Using Systems Change to Increase Cancer Screening Colorectal Cancer Screening: The Science Behind the Guidelines September 2017 Jeff Hostetter, MD Based
More informationColorectal Cancer Screening
Tool 2.1 Cancer Screening Basic Fact Sheet Are You at High Risk? Your risk for colorectal cancer may be higher than average if: stomach You or a close relative have had colorectal polyps or colorectal
More information2. Describe pros/cons of screening interventions (including colonoscopy, CT colography, fecal tests)
Learning Objectives 1. Review principles of colon adenoma/cancer biology that permit successful prevention regimes 2. Describe pros/cons of screening interventions (including colonoscopy, CT colography,
More informationDiagnostics for the early detection and prevention of colon cancer. Publication of DeeP-C Study Data in New England Journal of Medicine March 2014
Diagnostics for the early detection and prevention of colon cancer Publication of DeeP-C Study Data in New England Journal of Medicine March 2014 Safe Harbor Statement Certain statements made in this presentation
More informationThe Use of Quality Measures in Colorectal Cancer Screening
The Use of Quality Measures in Colorectal Cancer Screening Susan Hutfless PhD Johns Hopkins University School of Medicine, Division of Gastroenterology & Johns Hopkins Bloomberg School of Public Health,
More informationMedicare Shared Savings Program Accountable Care Organization (ACO) Measures Deep Dive Series
Medicare Shared Savings Program Accountable Care Organization (ACO) Measures Deep Dive Series Preventive Care and Screening (PREV-6): Measure 19 Colorectal Cancer Screening ACO_QRM19PPTv9_0518_IA Approved
More informationCancer Screenings and Early Diagnostics
Cancer Screenings and Early Diagnostics Ankur R. Parikh, D.O. Medical Director, Center for Advanced Individual Medicine Hematologist/Medical Oncologist Atlantic Regional Osteopathic Convention April 6
More informationACG Clinical Guideline: Colorectal Cancer Screening
ACG Clinical Guideline: Colorectal Cancer Screening Douglas K. Rex, MD, FACG 1, David A. Johnson, MD, FACG 2, Joseph C. Anderson, MD 3, Phillip S. Schoenfeld, MD, MSEd, MSc (Epi), FACG 4, Carol A. Burke,
More information